NeoLight’s jaundice treatment catches another $7 million to bring neonatal light therapy to the home

NeoLight, a startup company that’s working to bring hospital-grade neonatal care technologies to the home, has raised $ 7 million more in financing.

Dignity Health and Honor Health Systems came in to support the company along with previous investors like the Pittsburgh Steelers quarterback Ben Roethlisberger and his wife Ashley and other, undisclosed investors. 

Initially intended for hospital use, the company pivoted to pitch its hardware to new parents since they’re now being encouraged to take newborns home as soon as possible so that they can be quarantined.

The company’s light therapies are designed to treat conditions like jaundice, which occurs in roughly 60% of newborns and can lead to brain damage if left untreated, according to a statement from the company.

“The challenge is that the doctor may not know if treatment is necessary until the newborn is three or four days old, often after the baby has gone home from the hospital,” company founder Vivek Kopparthi said in a statement.

 

Startups – TechCrunch

Belgian startup Oncomfort offers VR-powered pain and anxiety treatment; raises €10M in Series A funding

Virtual Reality (VR) technology has progressed immensely in recent years, impacting various sectors, especially the medical industry. However, most people these days equate VR to video games and other forms of entertainment. The technology’s medical use-cases, although lacking the limelight, are perhaps the most beneficial and incorporate medical education, managing chronic pain and a lot of other scenarios.

Belgian startup Oncomfort specialises in ‘Digital Sedation’ – a novel method for relieving patients’ pain and anxiety through treatment with therapeutic Virtual Reality; and it just raised €10M in Series A funding. 

Raised €10M to further develop digital sedation

Brussels-based Oncomfort has raised  €10M Series A funding round co-led by Debiopharm and Crédit Mutuel Innovation. The investment includes support from Wallonia Innovation and Growth (W.IN.G) and the existing investors. Both institutional investors will join Oncomfort’s newly composed Board of Directors. The company intends to use the funding to develop its digital therapy solutions further and accelerate its international expansion.

“We are at a tipping point in our digital therapy,” says Mario Huyghe, CEO of Oncomfort. “The medical community has discovered the advantages and potential of ‘Digital Sedation’ to relieve pain and anxiety without medication. Virtual Reality acts as an enabler for this digital therapy. Yet, Oncomfort’s true potential comes from the scientific evidence of its digital sedation and the multidisciplinary co-creation with the expertise of anesthesiologists, neurologists, psychologists, and hypnotherapists. With this Series A funding, we will accelerate our product development with a broader engineering team and invest in the international expansion of Oncomfort.”

“Our investment in Oncomfort’s digital sedation solution is based on the strong potential of digital therapeutics as well as the specific intellectual property and scientific evidence that Oncomfort has built over recent years,” continued Karine Lignel, CEO of Crédit Mutuel Innovation.

“With this investment in Oncomfort, we want to push the boundaries to inspire healthcare stakeholders to acknowledge that there is much more we can do for patients through digital technology,” said Tanja Dowe, CEO of Debiopharm Innovation Fund.

How Oncomfort achieves this?

Founded in 2017 by Diane Jooris, and Joowon Kim, the startup specialises in ‘Digital Sedation’, which, according to the company, is a novel method for relieving patients’ pain and anxiety through treatment with clinically proven sessions of therapeutic Virtual Reality

The company launched ‘Sedakit’, a portable solution that dissociates patients from the clinical environment. The startup claims that the procedure ranges from light sedation (distraction) to deep sedation (dissociation) and is accessible for both adults and children for a wide range of medical interventions. 

Helped over 30,000 patients

Ever since the launch of the Sedakit in Benelux and France in June 2019, over 30,000 patients have been treated with this solution. 

Interestingly, studies have found VR to be effective as an addition to anesthesia to reduce pain and anxiety for patients. The VR immersion is designed to provide patients with a relaxing virtual environment to fight anxiety. The University of Washington has already developed virtual reality therapy of this sort – SnowWorld, a snowy virtual environment that helps burn victims to cope with their pain.

Main image credits: Oncomfort

The post Belgian startup Oncomfort offers VR-powered pain and anxiety treatment; raises €10M in Series A funding appeared first on Silicon Canals .

Startups – Silicon Canals

[Insightec in BioSpectrum] INSIGHTEC receives reimbursement from Japan for treatment of parkinson’s disease

Israel based INSIGHTEC®, a global medical technology innovator of incisionless surgery, recently announced that it has received national reimbursement from the Japanese Ministry of Health, Labour and Welfare (MHLW) for treating Parkinson’s disease.

Read more here.

The post [Insightec in BioSpectrum] INSIGHTEC receives reimbursement from Japan for treatment of parkinson’s disease appeared first on OurCrowd Blog.

OurCrowd Blog

Aetion Adds Another $19M to its Series B to Make Sense of Drug Development and Treatment Data

Clinical data has the potential to transform the healthcare system and we are in the midst of a healthcare data revolution. However, health care data can be unique and difficult to measure. Aetion, the Real World Evidence Platform®, allows the healthcare industry to make critical decisions about treatments and drug development from a high-level and detailed perspective.  Real World Evidence leads to informed decision-making and Aetion, founded by two physicians from Harvard, enables this with a focus on technology and big data. CEO Carolyn Magill shares more about how the company powers regulators, biopharma, payers, and health technology assessment (HTA) bodies, the company’s future plans, and  Aetion’s Series B, which brings the total round size to $ 82B extension. Aetion has now raised a total of $ 93.6M across five rounds.
AlleyWatch

[Insightec in WFMZ] Novant Health is first in the Carolinas to offer incisionless brain surgery for treatment of essential and Parkinson’s tremor

Novant Health has partnered with INSIGHTEC, a global medical technology innovator to bring this breakthrough technology to Charlotte. It will be the only hospital system between central Virginia and Florida to offer this new incisionless treatment of tremor.

Read more here.

The post [Insightec in WFMZ] Novant Health is first in the Carolinas to offer incisionless brain surgery for treatment of essential and Parkinson’s tremor appeared first on OurCrowd Blog.

OurCrowd Blog

[MeMed in GlobeNewsWire] Prospective Study Finds Potential Utility of MeMed’s Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients

Researchers at Israel’s Rabin Medical Center (comprised of Beilinson and Hasharon Hospitals) in collaboration with MeMed, have published prospective data on the potential utility of the analysis of IP-10, a host immune biomarker, in managing the care and treatment of patients with severe COVID-19 infection.

Read more here.

The post [MeMed in GlobeNewsWire] Prospective Study Finds Potential Utility of MeMed’s Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients appeared first on OurCrowd Blog.

OurCrowd Blog

[RealView Imaging in Israel Hayom] Israeli startup makes medical treatment using floating holograms a reality

A startup based in northern Israel has made that a reality. And it seems that investors are enthusiastic about the idea, too – last week, RealView Imaging raised $ 10 million in a Series C round of financing. RealView Imaging’s Holoscope-i system creates 3D volumetric holograms based on data from medical imaging, which float in free space, allowing physicians a unique form of access to the patient’s anatomy during invasive procedures.

Read more here.

The post [RealView Imaging in Israel Hayom] Israeli startup makes medical treatment using floating holograms a reality appeared first on OurCrowd Blog.

OurCrowd Blog

ENT Disorder Treatment Market by Trends, Dynamic Innovation in Technology and Key Players – 3rd Watch News

ENT Disorder Treatment Market by Trends, Dynamic Innovation in Technology and Key Players  3rd Watch News
“nigeria startups when:7d” – Google News

Neurodegenerative Disease Treatment Market 2020 Trends, Quality, Reliability, and User Demands – Cole of Duty

Neurodegenerative Disease Treatment Market 2020 Trends, Quality, Reliability, and User Demands  Cole of Duty
“nigeria startups when:7d” – Google News

Anti-Snoring Treatment Market Revenue, Export, and Import Status of Each Region – 2026 – Cole of Duty

Anti-Snoring Treatment Market Revenue, Export, and Import Status of Each Region – 2026  Cole of Duty
“nigeria startups when:7d” – Google News